Arterial spin-labeling assessment of normalized vascular intratumoral signal intensity as a predictor of histologic grade of astrocytic neoplasms

American Journal of Neuroradiology

Volumn 35, Issue 3, 2014, Pages 482-489

  Furtner, Julia ^a   Schopf V ^a   Schewzow, K ^a   Kasprian, G ^a   Weber, M ^a   Woitek, R ^a   Asenbaum, U ^a   Preusser, M ^a   Marosi, C ^a   Hainfellner, J A ^a,b   Widhalm, G ^a   Wolfsberger, S ^a   Prayer, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NORMALIZED VASCULAR INTRATUMORAL SIGNAL INTENSITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGICAL PARAMETERS; SIGNAL DETECTION; SPIN LABELING; TUMOR CLASSIFICATION; VERY ELDERLY; WORLD HEALTH ORGANIZATION; YOUNG ADULT; BRAIN TUMOR; CANCER GRADING; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY;

SPIN LABELING;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; SPIN LABELS; YOUNG ADULT;

EID: 84896441019     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3705     Document Type: Article

References (30)

1. Wöhrer A, Waldhör T, Heinzl H, et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J NeuroOncol 2009;95:401-11
2. Surawicz TS, McCarthy BJ, Kupelian V, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. NeuroOncol 1999;1:14-25
3. Pope WB, Sayre J, Perlina A, et al. MRimaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466-74
4. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62:2152-65 (Pubitemid 18261854)
5. Knopp E, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighed MR imaging. Radiology 1999;211: 791-98 (Pubitemid 29249482)
6. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-55 (Pubitemid 38657655)
7. Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 2010;31:40-48
8. Golay X, Petersen E. Arterial spin labeling: benefits and pitfalls of high magnetic field. Neuroimaging Clin North Am 2006;16:259-68 (Pubitemid 43775486)
9. Chen Y, Wang DJJ, Detre JA. Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging 2011;33:940-49
10. Järnum H, Steffensen EG, Knutsson L, et al. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 2010;52:307-17
11. Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228:523-32 (Pubitemid 36910097)
12. Weber M-A, Günther M, Lichy MP, et al. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue. Invest Radiol 2003;38:712-18 (Pubitemid 38004496)
13. Hirai T, Kitajima M, Nakamura H, et al. Quantitative blood flow measurements in gliomas using arterial spin-labeling at 3T: intermodality agreement and inter- and intraobserver reproducibility study. AJNR Am J Neuroradiol 2011;32:2073-79
14. Koziak AM, Winter J, Lee T-Y, et al. Validation study of a pulsed arterial spin labeling technique by comparison to perfusion computed tomography. Magn Reson Imaging 2008;26:543-53 (Pubitemid 351508342)
15. Weber M-A, Henze M, Tüttenberg J, et al. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Invest Radiol 2010;45:755-68
16. Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228-34
17. Lu H, Clingman C, Golay X, et al. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 2004;52:679-82 (Pubitemid 39108984)
18. Kim MJ, Kim HS, Kim J-H, et al. Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading. Acta Radiol 2008;49:450-57 (Pubitemid 351598801)
19. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214-21 (Pubitemid 38235298)
20. Wong EC, Buxton RB, Frank LR. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed 1997;10:237-49 (Pubitemid 27519924)
21. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963-72
22. Hendrikse J, Van Osch M, Rutgers D, et al. Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology 2004;233:899-904
23. MacIntosh BJ, Filippini N, Chappell MA, et al. Assessment of arterial arrival times derived from multiple inversion time pulsed arterial spin labeling MRI. Magn Reson Med 2010;63:641-47
24. Chawla S, Wang S, Wolf RL, et al. Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas. AJNR Am J Neuroradiol 2007;28:1683-89 (Pubitemid 47598140)
25. Liu P, Uh J, Lu H. Determination of spin compartment in arterial spin labeling MRI. Magn Reson Med 2011;65:120-27
26. Wolf RL, Wang J, Wang S, et al. Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 2005;22:475-82 (Pubitemid 41416406)
27. Barker FG, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936-41 (Pubitemid 27360923)
28. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-98 (Pubitemid 37444849)
29. Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 2009;27:4733-40
30. Vredenburgh JJ, Desjardins A, Herndon JE, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 2007; 25:4722-29 (Pubitemid 350086473)